US Stock MarketDetailed Quotes
NTRB Nutriband
- 4.960
- +0.230+4.86%
Close Nov 18 16:00 ET
55.04MMarket Cap-6123P/E (TTM)
5.000High4.640Low17.09KVolume4.720Open4.730Pre Close81.83KTurnover0.34%Turnover RatioLossP/E (Static)11.10MShares9.59552wk High4.42P/B25.32MFloat Cap2.22052wk Low--Dividend TTM5.11MShs Float10.560Historical High--Div YieldTTM7.61%Amplitude1.530Historical Low4.787Avg Price1Lot Size
About Nutriband Company
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.
Company Profile
SymbolNTRB
Company NameNutriband
Listing DateOct 1, 2021
Founded2012
CEOMr. Gareth Sheridan
MarketNASDAQ
Employees13
Fiscal Year Ends01-31
Address121 South Orange Avenue,Suite 1500
CityOrlando
ProvinceFlorida
CountryUnited States of America
Zip Code32801
Phone1-407-377-6695
Websitehttp://www.nutriband.com
Company Executives
- Name
- Position
- Salary
- Gareth Sheridan
- Chief Executive Officer and Director
- 378.67K
- Dr. Jeff Patrick, Pharm.D.
- Chief Scientific Officer
- --
- Gerald Goodman
- Chief Financial Officer and Principal Accounting Officer
- 274.98K
- Dr. Alan Smith, PhD
- Chief Operating Officer and President of 4P Therapeutics
- 236.49K
- Serguei Melnik
- Chairman of the Board, President and Secretary
- 346.67K
- Sergei Glinka
- Director
- --
- Irina Gram
- Independent Director
- 32.31K
- Radu Bujoreanu
- Independent Director
- 40.66K
- Mark Hamilton
- Independent Director
- 32.31K
- Dr. Stefani C. Mancas, PhD
- Independent Director
- 32.31K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data